Rapid automated antimicrobial susceptibility testing of Streptococcus pneumoniae by use of the bioMerieux VITEK 2

Journal of Clinical Microbiology

Volumn 38, Issue 8, 2000, Pages 2814-2818

  Jorgensen, J H ^a   Barry, A L ^a   Traczewski, M M ^a   Sahm, D F ^a   McElmeel, M L ^a   Crawford, S A ^a  

^a Mays Cancer Center at UT Health San Antonio   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; CEFOTAXIME; CEFTRIAXONE; CHLORAMPHENICOL; COTRIMOXAZOLE; ERYTHROMYCIN; OFLOXACIN; PENICILLIN DERIVATIVE; TETRACYCLINE; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; AUTOANALYSIS; BACTERIUM ISOLATE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; STRAIN DIFFERENCE; STREPTOCOCCUS; STREPTOCOCCUS PNEUMONIAE;

STREPTOCOCCUS PNEUMONIAE;

EID: 0033884747     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/jcm.38.8.2814-2818.2000     Document Type: Article

References (20)

1. Emergence of drug-resistant pneumococcal infections in the United States
2. The continued emergence of drug-resistant Streptococcus pneumoniae in the United States: An update from the Centers for Disease Control and Prevention's pneumococcal sentinel surveillance system
3. Geographic variation in penicillin resistance in Streptococcus pneumoniae - Selected sites, United States
4. Decreased susceptibility of Streptococcus pneumoniae to fluoroquinolones in Canada
5. Antimicrobial resistance with Streptococcus pneumoniae in the United States, 1997-98
6. Mortality from invasive pneumococcal pneumonia in the era of antibiotic resistance, 1995-1997
7. Antimicrobial resistance among lower respiratory tract isolates of Streptococcus pneumoniae; Results of a 1992-1993 Western Europe and USA collaborative surveillance study
8. Antimicrobial susceptibility testing: Special needs for fastidious organisms and difficult-to-detect resistance mechanisms
9. Detection of penicillin and extended-spectrum cephalosporin resistance among Streptococcus pneumoniae clinical isolates by use of the E test
10. Evaluation of the Dade MicroScan MICroSTREP antimicrobial susceptibility testing panel with selected Streptococcus pneumoniae challenge strains and recent clinical isolates
11. Development of interpretive criteria and quality control limits for broth microdilution and disk diffusion antimicrobial susceptibility testing of Streptococcus pneumoniae
12. Activities of newer fluoroquinolones against Streptococcus pneumoniae clinical isolates including those with mutations in the gyrA, parC, and parE loci
13. The clinical relevance of in-vitro resistance to penicillin, ampicillin, amoxycillin, and alternative agents, for the treatment of community-acquired pneumonia caused by Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis
14. Identification of multiple clones of extended-spectrum cephalosporin-resistant Streptococcus pneumoniae isolates in the United States
15. Resistance to penicillin and cephalosporin and mortality from severe pneumococcal pneumonia in Barcelona, Spain
16. Canadian national survey of prevalence of antimicrobial resistance among clinical isolates of Streptococcus pneumoniae
17. Surveillance of antimicrobial resistance in Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the United States in 1996-1997 respiratory season